Skip to main content
SpringerLink
Log in

Environmental Factors in the Epidemiology of Inflammatory Bowel Disease

  • Chapter
  • First Online:
Crohn's Disease and Ulcerative Colitis

Abstract

The occurrence of IBD has been increasing in Western Europe and North America [1, 2] over several decades after the Second World War. It has been assumed that socioeconomic factors represent the most important explanation for this increase [3]. A part of this increase may have been related to more awareness and recognition of the diseases, as well as generally better registration in all countries.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Munkholm P, Langholz E, Nielsen OH, et al. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962–87: a sixfold increase in incidence. Scand J Gastroenterol. 1992;27:609–14.

    Article  CAS  PubMed  Google Scholar 

  2. Lofthus EV. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology. 2004;126:1504–17.

    Article  Google Scholar 

  3. Duggan AE, Usmani I, Neal KR, Logan RFA. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut. 1998;43:494–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24 Suppl 170:2–6.

    Article  Google Scholar 

  5. Logan RFA. Inflammatory bowel disease incidence: up, down or unchanged? Gut. 1998;42:309–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sonnenberg A, McCarty DJ, Jacobsen SJ. Geographic variation in the incidence of and mortality from inflammatory bowel disease. Dis Colon Rectum. 1986;29:854–61.

    Article  CAS  PubMed  Google Scholar 

  7. Primatesta P, Goldacre MJ. Crohn’s disease and ulcerative colitis in England and the Oxford Record linkeage study area: a profile of hospitalized morbidity. Int J Epidemiol. 1995;24:922–8.

    Article  CAS  PubMed  Google Scholar 

  8. Cosnes J, Cattan S, Blain A, et al. Long-term evolution of disease behavior of Crohn’s disease. Inflamm Bowel Dis. 2002;8:244–50.

    Article  PubMed  Google Scholar 

  9. Vind I, Riis L, Knudsen E, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen city and county, 2003–2005: a population based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006;101:1274–82.

    Article  PubMed  Google Scholar 

  10. Shivananda S, Lennard-Jones J, Logan RFA, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut. 1996;39:690–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of south-eastern Norway 1990–1993. A large prospective population-based study. Scand J Gastroenterol. 1996;31:356–60.

    Google Scholar 

  12. Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn’s disease in four counties of south-eastern Norway 1990–1993. A large prospective population-based study. Scand J Gastroenterol. 1996;31:350–4.

    Google Scholar 

  13. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population based study. Am J Gastroenterol. 2006;101:1559–68.

    Article  PubMed  Google Scholar 

  14. Jess T, Lofthus Jr EV, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006;12:669–76.

    Article  PubMed  Google Scholar 

  15. Hildebrand H, Finkel Y, Grahnquist L, et al. Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990–2001. Gut. 2003;52:1432–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Perminow G, Frigessi A, Rydning A, et al. Incidence and clinical presentation of IBD in children: comparison between prospective and retrospective data in a selected Norwegian population. Scand J Gastroenterol. 2006;41:1433–9.

    Article  PubMed  Google Scholar 

  17. Perminow G, Brackmann S, Lyckander LG, et al. Characterization in childhood inflammatory bowel disease. A new population-based inception cohort from South-Eastern Norway, 2005–07, showing increased incidence in Crohn’s disease. Scand J Gastroenterol. 2008;43:1–11.

    Article  Google Scholar 

  18. Lehtinen P, Ashorn M, Iltanen S, et al. Incidence trends of pediatric inflammatory bowel disease in Finland, 1987–2003, a nationwide study. Inflamm Bowel Dis. 2010 [Epub ahead of print]. PMID: 21080459

    Google Scholar 

  19. Manninen P, Karvonen A-L, Huhtala H, et al. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol. 2010;45:1063–7.

    Article  PubMed  Google Scholar 

  20. Lakatos L, Lakatos PL. Changes in the epidemiology of inflammatory bowel diseases. Orv Hetil. 2007;148:223–8.

    Article  PubMed  Google Scholar 

  21. Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:325–33.

    Article  PubMed  Google Scholar 

  22. Wolthers F, Russel MG, Sijbrandij J, et al. Phenotype at diagnosis predicts recurrence rates in Crohn’s disease. Gut. 2006;55:1124–30.

    Article  Google Scholar 

  23. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patients characteristics may predict 10-years disease recurrence in a European-wide population based cohort. Am J Gastroenterol. 2007;102:1692–701.

    Article  PubMed  Google Scholar 

  24. Goh KL, Xiao S-D. Inflammatory bowel disease: a survey of the epidemiology in Asia. J Dig Dis. 2010;10:1–6.

    Article  Google Scholar 

  25. Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of IBDs in midwestern of Sao Paulo State, Brazil. Arq Gastroenterol. 2009;46:20–5.

    Article  PubMed  Google Scholar 

  26. Kurata JH, Kantor-Fish S, Frankl H, et al. Crohn’s disease among ethnic groups in a large health maintenance organization. Gastroenterology. 1992;102:1940–8.

    Article  CAS  PubMed  Google Scholar 

  27. Heresbach D, Gulwani-Alkolkar B, Lesser M, et al. Anticipation in Crohn’s disease may be influenced by gender and ethnicity of the transmitting parent. Am J Gastroenterol. 1998;93:2368–72.

    Article  CAS  PubMed  Google Scholar 

  28. Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 2000;95:693–8.

    Article  CAS  PubMed  Google Scholar 

  29. Zheng JJ, Zhu XS, Huangfu Z, Gao ZX, Guo ZR, Wang Z. Crohn’s disease in mainland China: a systematic analysis of 50 years of research. Chin J Dig Dis. 2005;6:175–81.

    Article  PubMed  Google Scholar 

  30. Desai HG, Gupte PA. Increasing incidence of Crohn’s disease in India: is it related to improved sanitation? Indian J Gastroenterol. 2005;24:23–4.

    CAS  PubMed  Google Scholar 

  31. Bernstein CN, Shanahan F. Disorders of a modern lifestyle: reconciling the epidemiology of inflammatory bowel diseases. Gut. 2008;57:1185–91.

    Article  PubMed  Google Scholar 

  32. Calkins BM, Lilienfeld AM, Garland CF, et al. Trends and incidence rates of ulcerative colitis and Crohn’s disease. Dig Dis Sci. 1984;29:913–20.

    Article  CAS  PubMed  Google Scholar 

  33. Garland CF, Lilienfield AM, Mendeloff AI, et al. Incidence rates of ulcerative colitis and Crohn’s disease in fifteen areas of the United States. Gastroenterology. 1981;81:1115–24.

    CAS  PubMed  Google Scholar 

  34. Nerich V, Monnet E, Etienne OA, et al. Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis. 2006;12:218–26.

    Article  PubMed  Google Scholar 

  35. Kiledebo S, Breckan R, Norgaard K, et al. The incidence of Crohn’s disease in northern Norway from 1983 to 1986. Scand J Gastroenterol. 1989;24:1265–70.

    Article  Google Scholar 

  36. Haug K, Schrumpf E, Halvorsen JF, et al. Epidemiology of Crohn’s disease in Western Norway. Scand J Gastroenterol. 1989;24:1271–5.

    Article  CAS  PubMed  Google Scholar 

  37. Smith LA, Rameshanker R, Healy J, et al. An unusual prevalence of inflammatory bowel disease in a multiethnic population-single centre UK data. Gut. 2010;59(Suppl III):A181.

    Google Scholar 

  38. Ott C, Obermaier F, Thieler S, et al. The incidence of inflammatory bowel disease in a rural region of southern Germany: a prospective population based study. Eur J Gastroenterol Hepatol. 2008;20:917–23.

    Article  PubMed  Google Scholar 

  39. Frank DNA, St Amand AL, Feldman RA, et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A. 2007;104:13780–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hugot J-P, Alberti C, Berrebi D, Bingen E, Cezard J-P. Crohn’s disease: the cold chain hypothesis. Lancet. 2003;362:2012–5.

    Article  CAS  PubMed  Google Scholar 

  41. Forbes A, Kalantzis T. Crohn’s disease: the cold chain hypothesis. Int J Colorectal Dis. 2006;21:399–401.

    Article  PubMed  Google Scholar 

  42. Malekzadeh F, Alberti C, Nouraei M, et al. Crohn’s disease and early exposure to domestic refrigeration. PLoS ONE. 2009;4(1):e4288.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Luther J, Dave M, Higgins PDR, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis. 2009;16:1077–84.

    Article  Google Scholar 

  44. Koloski N-A, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: a critical review of the literature. World J Gastroenterol. 2008;14:165–73.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Korzenik JR. Past and current theories of etiology of IBD: toothpaste, worms, and refrigerators. J Clin Gastroenterol. 2005;39(4 Suppl 2):S59–65.

    Article  PubMed  Google Scholar 

  46. Chacon O, Bermudez LE, Barletta RG. Johne’s disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol. 2004;58:329–63.

    Article  CAS  PubMed  Google Scholar 

  47. Bernstein CN, Blanchard JF, Rawsthorne P, Collins MT. Population-based case control study of seroprevalence of Mycobacterium paratuberculosis in patients with Crohn’s disease and ulcerative colitis. J Clin Microbiol. 2004;42:1129–35.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Feller M, Huwiler K, Stephan R, et al. Mycobacterium avium subspecies paratuberculosis and Crohn’s disease: a systematic review and meta-analysis. Lancet Infect Dis. 2007;7:607–13.

    Article  PubMed  Google Scholar 

  49. Ricanek P, Lothe SM, Szpinda I, et al. Paucity of mycobacteria in mucosal bowel biopsies from adults and children with early inflammatory bowel disease. J Crohn’s Colitis. 2010;4:561–6.

    Article  Google Scholar 

  50. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease. Gastroenterology. 2004;127:412–21.

    Article  PubMed  Google Scholar 

  51. Sonnenberg A. Similar geographic variations of mortality and hospitalization associated with IBD and Clostridium difficile colitis. Inflamm Bowel Dis. 2010;16:487–93.

    Article  PubMed  Google Scholar 

  52. Hildebrand H. On the generality of the latitudinal diversity gradient. Am Nat. 2004;163:192–211.

    Article  Google Scholar 

  53. Aamodt G, Bukholm G, Jahnsen J, et al. The association between water supply and inflammatory bowel disease based on a 1990–1993 cohort study in southeastern Norway. Am J Epidemiol. 2008;168:1065–72.

    Article  PubMed  Google Scholar 

  54. Lerner A. Aluminum is a potential environmental factor for Crohn’s disease induction. Extended hypothesis. Ann N Y Acad Sci. 2007;1107:329–45.

    Article  CAS  PubMed  Google Scholar 

  55. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epi-phenomenon or the cause? Dig Dis Sci. 2007;52:2015–21.

    Article  PubMed  Google Scholar 

  56. Hayes CE, Nashold FE, Froicu M, et al. The immunological functions of the vitamin D endocrine system. Cell Mol Biol (Noisy-le-Grand). 2003;49:277–300.

    CAS  Google Scholar 

  57. Ekbom A, Adami HO, Helmick CG, Jonzon A, Zack MM. Perinatal risk factors for inflammatory bowel disease: a case-control study. Am J Epidemiol. 1990;132:1111–9.

    Article  CAS  PubMed  Google Scholar 

  58. Klement E, Lysy J, Hoshen M, Avitan M, Goldin E, Israeli E. Childhood hygiene is associated with the risk for inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2008;103:1775–82.

    Article  PubMed  Google Scholar 

  59. Radon K. Contact with farm animals in early life and juvenile inflammatory bowel disease: a case-control study. Pediatrics. 2007;120:354–61.

    Article  PubMed  Google Scholar 

  60. Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci. 1994;39:555–60.

    Article  CAS  PubMed  Google Scholar 

  61. Green C, Elliott L, Beaudoin C, Bernstein CN. A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006;164:615–23. discussion 624–28.

    Article  PubMed  Google Scholar 

  62. Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol. 2002;37:1301–8.

    Article  CAS  PubMed  Google Scholar 

  63. Bengtson M-B, Solberg C, Aamodt G, et al. Clustering in time of familial IBD separates ulcerative colitis and Crohn’s disease. Inflamm Bowel Dis. 2009;15:1867–74.

    Article  PubMed  Google Scholar 

  64. Lashner BA, Loftus Jr EV. True or false? The hygiene hypothesis for Crohn’s disease. Am J Gastroenterol. 2006;101:1003–4.

    Article  PubMed  Google Scholar 

  65. Amre DK, Lambrette P, Law L, et al. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn’s disease: a case-control study. Am J Gastroenterol. 2006;101:1005–11.

    Article  PubMed  Google Scholar 

  66. Bernstein CN, Rawsthorne P, Cheang M, Blanchard JF. A population-based case control study of potential risk factors for IBD. Am J Gastroenterol. 2006;101:993–1002.

    Article  PubMed  Google Scholar 

  67. Feeney MA, Murphy F, Clegg AJ, Trebble TM, Sharer NM, Snook JA. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol. 2002;14:529–34.

    Article  PubMed  Google Scholar 

  68. Sonnenberg A. Disability from inflammatory bowel disease among employees in West Germany. Gut. 1989;30:367–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Sonnenberg A. Occupational distribution of inflammatory bowel disease among German employees. Gut. 1990;31:1037–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Solberg IC, Vatn MH, Hoie O, et al. Clinical course in Crohn’s disease: results of a population based ten-year follow-up study. Clin Gastroenterol Hepatol. 2007;5:1430–8.

    Article  PubMed  Google Scholar 

  71. Mahid SS, Minor KS, Soto RE, et al. Smoking and inflammatory bowel disease: a meta analysis. Mayo Clin Proc. 2006;81:1462–71.

    Article  PubMed  Google Scholar 

  72. Russel RK, Farhodi R, Wilson M, et al. Perinatal passive smoke exposure may be more important than childhood exposure in the risk of developing childhood IBD. Gut. 2005;54:1500–1.

    Google Scholar 

  73. Regueiro M, Kevin EK, Onki C, et al. Cigarette smoking and age at diagnosis of inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:42–7.

    Article  PubMed  Google Scholar 

  74. Bridger S, Lee JCW, Bjarnason L, et al. Inflammatory bowel disease. In siblings with similar genetic susceptibility for inflammatory bowel disease, smokers tend to develop Crohn’s disease and non-smokers develop ulcerative colitis. Gut. 2002;51:21–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Yamamoto T, Nakahigashi M, Saniabadi AR. Review article: diet and inflammatory bowel disease-epidemiology and treatment. Aliment Pharmacol Ther. 2009;30:99–112.

    Article  CAS  PubMed  Google Scholar 

  76. Graham TO, Kandil HM. Nutritional factors in inflammatory bowel disease. Gastroenterol Clin N Am. 2002;31:203–18.

    Article  Google Scholar 

  77. Han PD, Burke A, Baldassano N, Rombeau JL, Lichtensein GR. Nutrition and inflammatory bowel disease. Gastroenterol Clin N Am. 1999;28:423–43.

    Article  CAS  Google Scholar 

  78. Corrao C, Traguone A, Caprilli R, et al. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breast feeding in Italy: a nationwide case-control study. Int J Epidemiol. 1998;27:397–404.

    Article  CAS  PubMed  Google Scholar 

  79. Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr. 2004;80:1342–52.

    CAS  PubMed  Google Scholar 

  80. Baron S, Turck D, Leplat C, et al. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut. 2005;54:357–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Mikhailov TA, Furner SE. Breastfeeding and genetic factors in the etiology of inflammatory bowel disease in children. World J Gastroenterol. 2009;15:270–9.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Jantshou P, Morois S, Clavel-Chapelon F, Boutron-Ruault MC, Carbonell F. Animal protein intake and risk of inflammatory bowel disease: the E3N prospective study. Am J Gastroenterol. 2010;105:2195–201.

    Article  CAS  Google Scholar 

  83. Persson P-G, Ahlbom A, Hellers G. Diet and inflammatory bowel disease: a case-control study. Epidemiology. 1992;3:47–52.

    Article  CAS  PubMed  Google Scholar 

  84. Amre DK, D’Souza S, Morgan K, et al. Imbalances in dietary consumption of fatty acids, vegetables, and fruits are associated with risk for Crohn’s disease in children. Am J Gastroenterol. 2007;102:2016–25.

    Article  CAS  PubMed  Google Scholar 

  85. Geerling BJ, Dagnelie PC, Badart-Smook A, Russel MG, Stockbrugger RW, Brummer RJ. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol. 2000;95:1008–13.

    Article  CAS  PubMed  Google Scholar 

  86. Sakamoto N, Kono S, Wakai K, et al. Dietary risk factors for inflammatory bowel disease: a multicenter case-control study in Japan. Inflamm Bowel Dis. 2005;11:154–63.

    Article  PubMed  Google Scholar 

  87. Maconi G, Ardizzone S, Cucino C, Bezzio C, Russo AG, Bianchi-Porro G. Pre-illness changes in dietary habits and diet as a risk factor for inflammatory bowel disease: a case-control study. World J Gastroenterol. 2010;16:4297–304.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Shoda R, Matsueda K, Yamato S, Uemada N. Epidemiologic analysis of Crohn’s disease in Japan: increased dietary intake of n-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn’s disease in Japan. Am J Clin Nutr. 1996;63:741–5.

    CAS  PubMed  Google Scholar 

  89. Hart AR et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut. 2009;58:1606–11.

    Article  CAS  PubMed  Google Scholar 

  90. Hart AR, Luben R, Olsen A, et al. Diet in the aetiology of ulcerative colitis: a European prospective cohort study. Digestion. 2008;77:57–64.

    Article  PubMed  Google Scholar 

  91. Azakura H, Suzuki K, Kitahora T, Morizane T. Is there a link between food and intestinal microbes and the occurrence of Crohn’s disease and ulcerative colitis? J Gastroenterol Hepatol. 2008;23:1794–801.

    Article  Google Scholar 

  92. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn’s disease. Klin Wschr. 1976;54:367–71.

    Article  CAS  PubMed  Google Scholar 

  93. Penny WJ, Mayberry JF, Aggett PJ, et al. Relationship between trace elements, sugar consumption, and taste in Crohn’s disease. Gut. 1983;24:288–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  94. Katschinski B, Logan RFA, Edmond M, Langman MJS. Smoking and sugar intake are separate but interactive risk factors in Crohn’s disease. Gut. 1988;29:1202–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Silkoff K, Hallak A, Yegena L, et al. Consumption of refined carbohydrate by patients with Crohn’s disease in Tel-Aviv-Yafo. Postgrad Med J. 1980;56:842–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. Matsui T, Iida M, Fujishima M, et al. Increased sugar consumption in Japanese patients with Crohn’s disease. Gastroenterol Jpn. 1990;25:271.

    CAS  PubMed  Google Scholar 

  97. Tragnone A, Valpiani D, Miglio F, et al. Dietary habits as risk factors for inflammatory bowel disease. Eur J Gastroenterol Hepatol. 1995;7:47–51.

    CAS  PubMed  Google Scholar 

  98. James AH. Breakfast and Crohn’s disease. Br Med J. 1977;1:943–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to Baker’s yeast in Crohn’s disease. Digestion. 1994;55:40–3.

    Article  CAS  PubMed  Google Scholar 

  100. Mckenzie H, Main J, Pennington CR, Parrat D. Antibody to selected strains of Saccharomyces cervisiae (baker’s and brewer’s yeast) and candida albicans in Crohn’s disease. Gut. 1990;31:536–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Halfvarson J, Standaert-Vitse A, Järnerot G, et al. Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease. Gut. 2005;54:1237–43.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Lee G, Buchman AL. DNA-driven nutritional therapy of inflammatory bowel disease. Nutrition. 2009;25:885–91.

    Article  CAS  PubMed  Google Scholar 

  103. Beaudet al. Epigenetics and complex human disease: is there a role in IBD? J Pediatr Gastroenterol Nutr. 2008;46 Suppl 1:E2.

    Google Scholar 

  104. Lin Z, Hegarty JP, Cappel J, Yu W, Chen X, Faber P, et al. Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin Genet. 2010; doi:10.1111/j.1399-0004.2010.01546.x. [Epub ahead of print]

  105. Kosuda LL, Greiner DL, Bigazzi PE. Mercury-induced renal autoimmunity changes in RT6+ T-lymphocytes of susceptible and resistant rats. Environ Health Perspect. 1993;101:178–85.

    CAS  PubMed  PubMed Central  Google Scholar 

  106. Perl DP, Fogarty U, Harpaz N, et al. Bacterial-metal interactions: the potential role of aluminum and other trace elements in the etiology of Crohn’s disease. Inflamm Bowel Dis. 2004;10:881–3.

    Article  PubMed  Google Scholar 

  107. Lomer MCE, Harvey RSJ, Evans SM, et al. Efficacy and tolerability of a low microparticle diet in a double blind, randomized, pilot study in Crohn’s disease. Eur J Gastroenterol Hepatol. 2001;13:101–6.

    Article  CAS  PubMed  Google Scholar 

  108. Cipola G, Crema F, Sacco S, Moro E, di Ponti F, Frigo G. Anti-inflammatory drugs and inflammatory bowel disease: current perspectives. Pharmacol Res. 2002;46:1–6.

    Article  CAS  Google Scholar 

  109. Bjarnason I, Takeutchi K. Intestinal permeability in the pathogenesis of NSAID-induced enteropathy. Scand J Gastroenterol. 2009;44 Suppl 19:23–9.

    Article  CAS  Google Scholar 

  110. EI Miedany Y, Yossef S, Ahmed I, El Gafary M. The gastrointestinal safety and effect on disease activity of etoricoxib, a selective cox-2 inhibitor in inflammatory bowel diseases. Am J Gastroenterol. 2006;101:311–7.

    Article  CAS  Google Scholar 

  111. Sandler RS, Wurzelmann JI, Lyles CM. Oral contraceptive use and the risk of inflammatory bowel disease. Epidemiology. 1992;3:374–8.

    Article  CAS  PubMed  Google Scholar 

  112. Zappata LB, Paulen MB, Cancino C, Marchbanks PA, Curtis KM. Contraceptive use among women with inflammatory bowel disease: a systematic review. Contraception. 2010;82:72–85.

    Article  Google Scholar 

  113. Cornish JA, Tan E, Simillis C, Clark SK, Teare J, Tekkis PP. The risk of oral contraceptives in the etiology of inflammatory bowel disease: a meta-analysis. Am J Gastroenterol. 2008;103:2394–400.

    Article  PubMed  Google Scholar 

  114. Okori NI, Kane SV. Gender-related issues in the female inflammatory bowel disease patient. Expert Rev Gastroenterol Hepatol. 2009;3:145–54.

    Article  Google Scholar 

  115. Tysk C, Järnrot G. Seasonal variation in exacerbation of ulcerative colitis. Scand J Gastroenterol. 1993;28:95–6.

    Article  CAS  PubMed  Google Scholar 

  116. Moum B, Aadland E, Ekbom A, et al. Seasonal variation in the onset of ulcerative colitis. Gut. 1996;38:376–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Sonnenberg A. Date of birth in the occurrence of inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:206–11.

    Article  PubMed  Google Scholar 

  118. Kahn RR, Lawson AD, Minnich LL, Martin K, Nasir A, Emmet MK, et al. Gastrointestinal norovirus infection associated with exacerbation of inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:328–33.

    Article  Google Scholar 

  119. Aamodt G, Jahnsen J, Bengtson MB, et al. Geographic distribution and ecological studies of inflammatory bowel disease in southeastern Norway in 1990–1993. Inflamm Bowel Dis. 2008;14(7):984–91.

    Article  PubMed  Google Scholar 

  120. Lopez RD, Gabriel R, Cantero PJ, Moreno OR, Fernandez BM, Mate JJ. Association of MALTectomy (appendectomy and tonsillectomy) and inflammatory bowel disease: a familial case control study. Rev Esp Enferm Dig. 2001;93:303–14.

    Google Scholar 

  121. Firouzi F, Bahari A, Aghazadeh R, Zali MR. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case control study in Iran. Int J Colorectal Dis. 2006;21:155–9.

    Article  PubMed  Google Scholar 

  122. Gearry RB, Richardson AK, Frampton CM, Dodshun AJ, Barclay ML. Population based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol. 2010;25:227–8.

    Article  Google Scholar 

  123. Lopez-Serrano P, Perez-Calle JL, Perez-Fernandez MT, Fernandez-Font JM, Boixeda deMiguel D, Fernandez-Rodriguez CM. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case control study. Scand J Gastroenterol. 2010;45:1464–71.

    Article  PubMed  Google Scholar 

  124. Kontroubakis IE, Vlachonicolis IG, Kapsoritakis A, et al. Appendectomy, tonsillectomy, and risk of inflammatory bowel disease: a case-controlled study in Crete. Dis Colon Rectum. 1999;42:225–30.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Gastroenterology, Oslo University Hospital, Nydalen, 4959, 0424, Oslo, Norway

    Morten H. Vatn M.D., Ph.D.

  2. Akershus University Hospital, Institute of Clinical Medicine, University of Oslo, 1474, Nordbyhagen, Akershus, Norway

    Morten H. Vatn M.D., Ph.D.

Authors
  1. Morten H. Vatn M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Morten H. Vatn M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Charité Medical School—Humboldt-University of Berlin, Berlin, Germany

    Daniel C. Baumgart

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Vatn, M.H. (2017). Environmental Factors in the Epidemiology of Inflammatory Bowel Disease. In: Baumgart, D. (eds) Crohn's Disease and Ulcerative Colitis. Springer, Cham. https://doi.org/10.1007/978-3-319-33703-6_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33703-6_1

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33701-2

  • Online ISBN: 978-3-319-33703-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation